Bill Gates fund invests in Australian start-up Atomo
Friday, August 12, 2016
An investment fund backed by Microsoft founder Bill Gates has taken a multimillion dollar stake in an Australian biotech start-up.
Atomo Diagnostics has invented quick, cheap and accurate tests for HIV, malaria and Ebola. Global Health Investment Fund purchased an 8.4 percent stake in the medical company for about A$3.3m (£1.9m, $2.5m). The fund, a joint venture between the Gates Foundation and JPMorgan, finances initiatives that benefit global health.
The US fund focuses on infectious diseases that include malaria, pre-eclampsia, cholera and river blindness. Atomo’s valuation after the latest round of investment is around A$30m.
Source: BBC (link opens in a new window)
- Health Care